OVOCA BIO PLC - EUR0.125
Share · IE00B4XVDC01 (XLON)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of OVOCA BIO PLC - EUR0.125
No Price
Company Profile for OVOCA BIO PLC - EUR0.125 Share
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Company Data
Name OVOCA BIO PLC - EUR0.125
Company Ovoca Bio plc
Website
https://ovocabio.com
Primary Exchange 
London
London
ISIN IE00B4XVDC01
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Timothy Rand McCutcheon
Country Ireland
Currency GBP
Employees 0,0 T
Address 17 Pembroke Street Upper, 2 Dublin
IPO Date 2000-01-04
Stock Splits
| Date | Split |
|---|---|
| 28.01.2026 | 1:3 |
| 18.01.2010 | 1:5 |
Ticker Symbols
| Name | Symbol |
|---|---|
| London | OVB.L |
More Shares
Investors who hold OVOCA BIO PLC - EUR0.125 also have the following shares in their portfolio:
